scispace - formally typeset
J

Jacques Arnaud

Researcher at Centre national de la recherche scientifique

Publications -  35
Citations -  741

Jacques Arnaud is an academic researcher from Centre national de la recherche scientifique. The author has contributed to research in topics: T-cell receptor & CD3. The author has an hindex of 13, co-authored 35 publications receiving 696 citations. Previous affiliations of Jacques Arnaud include Paul Sabatier University.

Papers
More filters
Journal ArticleDOI

Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins

TL;DR: The immunological conflict between ACPA and fibrin could sustain synovial inflammation not only via pro‐inflammatory effector mechanisms but also via impairment of fibrinolysis.
Journal ArticleDOI

Update on peptidylarginine deiminases and deimination in skin physiology and severe human diseases.

TL;DR: In this paper, the main biochemical, genetic and functional aspects of peptidylarginine deiminases (PADs) together with their pathophysiological implications are discussed.
Journal Article

Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.

TL;DR: ISH and immunohistochemical methods are more sensitive than Southern blot for detecting EBV in Hodgkin and Reed-Sternberg cells of Hodgkin's disease and this method offers the advantage of being applied to routinely processed tissue sections.
Journal ArticleDOI

Deimination is regulated at multiple levels including auto-deimination of peptidylarginine deiminases

TL;DR: Deimination can be regulated at multiple levels: transcription of the PADI genes, translation of the corresponding mRNAs, and auto-deimination of PADs.
Journal ArticleDOI

The antigen specificity of the rheumatoid arthritis-associated ACPA directed to citrullinated fibrin is very closely restricted.

TL;DR: It is demonstrated that only 3 immunodominant epitopes are targeted by ACPA on citrullinated fibrin stressing their actual oligoclonality, however, the reactivity to the 3 epitopes distinguishes three subgroups of patients.